Alcohol's Impact on Inflammatory Markers in HIV Disease - Russia ARCH Cohort

NCT01614626 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 351

Last updated 2020-12-17

No results posted yet for this study

Summary

The purpose of this study is to assess the longitudinal association between alcohol consumption and biomarkers of microbial translocation (sCD14) and inflammation/altered coagulation (IL-6/D-dimer); to establish a cohort of HIV-infected Russian drinkers; and to establish a sample repository.

Conditions

  • HIV Infection
  • Alcohol Use

Sponsors & Collaborators

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH
  • Boston Medical Center

    lead OTHER

Principal Investigators

  • Jeffrey Samet, MD, MA, MPH · Boston Medical Center

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2018-04-30
Completion
2020-12-15

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01614626 on ClinicalTrials.gov